Amidst the ceaseless ebb and flow of the financial ocean, news emerges of the Schall Law Firm casting a wide net in search of aggrieved parties among the investors of Fulcrum Therapeutics, Inc. (“Fulcrum” or “the Company”) bearing the FULC insignia on the NASDAQ mast. The Schall Law Firm, a stalwart in the realm of shareholder rights litigation, has set its sights on probing potential transgressions against securities laws.

The crescendo of this inquiry revolves around the veracity of the Company’s pronouncements. Did Fulcrum, under the scrutiny of future hindsight, set sail under the flag of falsity, neglecting to furnish investors with vital information, thus casting a shadow on their fiduciary duties? The tempest broke on September 12, 2024, when Fulcrum hoisted the flag, conceding that “its Phase 3 REACH trial evaluating losmapimod in patients with FSHD, did not achieve its primary endpoint of change from baseline in RSA with losmapimod compared to placebo. In addition, secondary endpoints did not achieve nominal statistical significance.” The aftershock was palpable, with Fulcrum’s shares plunging almost 60% in the morning skirmish of the market.

For those who find themselves adrift, grappling with losses incurred on this tumultuous voyage, a ray of hope emerges on the horizon. The Schall Law Firm extends an invitation, a lifeboat of sorts, urging the afflicted shareholders to step forward and claim what is rightfully theirs.

Brian Schall, the helmsman at the Schall Law Firm, awaits at the helm – perched at 2049 Century Park East, Suite 2460, an anchorage nestled in the bustling port of Los Angeles, CA 90067. He beckons you to embark on a voyage of consultation, a journey through the intricacies of your rights, all at no cost to your pocket. Reach out to us through the ether, dialing 310-301-3335, or navigate the digital channels to our abode at www.schallfirm.com. Alternatively, dispatch us an electronic epistle at bschall@schallfirm.com.

The Schall Law Firm, a bastion for investors enshrined in every corner of the globe, is a seasoned navigator in the turbulent waters of securities class action lawsuits and shareholder rights litigation, steering the damaged vessels to calmer seas.

As the stage curtains draw to a close on this missive, a caveat beckons for those residing in certain jurisdictions – behold, for this press release wears the garb of Attorney Advertising as defined by the laws and ethics statutes governing the land.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240912276585/en/